A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
Status:
RECRUITING
Trial end date:
2027-09-22
Target enrollment:
Participant gender:
Summary
This study is to investigate the ability of LXE408 to reduce or remove the level of parasites in the blood of people with chronic Chagas disease. Participants must have chronic Chagas disease without severe organ dysfunction.